BioStem Technologies, Inc.
BSEM Nasdaq
SEC CIK 1658678
Follow BioStem Technologies
Weekly email: filings, results
Revenue, last quarter
$7.6M
−27% vs same quarter last year
Net income
−$11.4M
−1594.7% vs same quarter last year
EPS, diluted
−$0.64
−2233.3% vs same quarter last year
Operating cash flow
−$8.8M
−273.5% vs same quarter last year
Source: SEC XBRL filings · latest filing